Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Tackling cancer in the developing world

Dr Christopher Wild - Director of IARC, Lyon, France
Tackling cancer in the developing world ( Dr Christopher Wild - Director of IARC, Lyon, France )
29 Jun 2016

Reducing inequalities in global health risk

Prof Sir Michael Marmot - UCL Institute of Health Equity, London, UK
Reducing inequalities in global health risk ( Prof Sir Michael Marmot - UCL Institute of Health Equity, London, UK )
29 Jun 2016

Results from the EURO-SKI cessation trial of TKIs in CML

Dr Johan Richter - Lund University, Lund, Sweden
Results from the EURO-SKI cessation trial of TKIs in CML ( Dr Johan Richter - Lund University, Lund, Sweden )
23 Jun 2016

Editor's ASCO 2016 Roundup

Prof Gordon McVie - ecancer Editor in Chief
Editor's ASCO 2016 Roundup ( Prof Gordon McVie - ecancer Editor in Chief )
16 Jun 2016

Multiple myeloma highlights from EHA 2016

Prof Marivi Mateos, Prof Meletios Dimopoulos, Prof Paul Richardson, Prof Philip McCarthy
Multiple myeloma highlights from EHA 2016 ( Prof Marivi Mateos, Prof Meletios Dimopoulos, Prof Paul Richardson, Prof Philip McCarthy )
10 Jun 2016

Ten years of letrozole improves survival and quality of life in early-diagnosed breast cancer.

Dr Julie Lemieux - Hôpital du Saint-Sacrement, Québec, Canada
Ten years of letrozole improves survival and quality of life in early-diagnosed breast cancer. ( Dr Julie Lemieux - Hôpital du Saint-Sacrement, Québec, Canada )
6 Jun 2016

Global drug pricing: How cost-effective is bevacizumab?

Dr Daniel Goldstein - Emory University, Atlanta, USA
Global drug pricing: How cost-effective is bevacizumab? ( Dr Daniel Goldstein - Emory University, Atlanta, USA )
6 Jun 2016

Phase I study of sapacitabine and seliciclib in patients with advanced solid tumours

Dr Sara Tolaney - Dana Farber Cancer Institute, Boston, USA
Phase I study of sapacitabine and seliciclib in patients with advanced solid tumours ( Dr Sara Tolaney - Dana Farber Cancer Institute, Boston, USA )
6 Jun 2016

METEOR trial: cabozantinib vs everolimus in advanced renal cell carcinoma

Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA
METEOR trial: cabozantinib vs everolimus in advanced renal cell carcinoma ( Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA )
5 Jun 2016

Patient engagement in The Metastatic Breast Cancer Project

Dr Nikhil Wagle - Dana-Farber Cancer Institute, Boston, USA
Patient engagement in The Metastatic Breast Cancer Project ( Dr Nikhil Wagle - Dana-Farber Cancer Institute, Boston, USA )
4 Jun 2016

Hypo-fractionation of prostate cancer radiotherapy

Dr Charles Catton - Princess Margaret Cancer Centre, Toronto, Canada
Hypo-fractionation of prostate cancer radiotherapy ( Dr Charles Catton - Princess Margaret Cancer Centre, Toronto, Canada )
3 Jun 2016

Use of novel agents in childhood ALL

Prof Lia Gore - Children's Hospital Colarado, Aurora, USA
Use of novel agents in childhood ALL ( Prof Lia Gore - Children's Hospital Colarado, Aurora, USA )
6 May 2016